Aqueous humor dynamics in monkeys in response to the kappa opioid agonist bremazocine

Transactions of the American Ophthalmological Society

Volumn 105, Issue , 2007, Pages 225-238

  Rasmussen, Carol A ^a   Gabelt, B'Ann True ^a   Kaufman, Paul L ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; BREMAZOCINE; NALOXONE; NORBINALTORPHIMINE;

ANIMAL EXPERIMENT; AQUEOUS HUMOR FLOW; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG RESPONSE; EYE REFRACTION; FLUOROPHOTOMETRY; INTRAOCULAR PRESSURE; MEAN ARTERIAL PRESSURE; MEASUREMENT; MIOSIS; MONKEY; NONHUMAN; PRESSURE MEASUREMENT; PRIORITY JOURNAL; PUPIL;

ANALGESICS; ANGIOTENSIN II; ANIMALS; AQUEOUS HUMOR; BENZOMORPHANS; BLOOD PRESSURE; INTRAOCULAR PRESSURE; MACACA FASCICULARIS; MODELS, ANIMAL; PUPIL; RECEPTORS, OPIOID, KAPPA;

EID: 47749117576     PISSN: None     EISSN: 15456110     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Kaufman PL, Mittag TW. Medical therapy of glaucoma. In: Kaufman PL, Mittag TW, eds. Glaucoma. London: Mosby-Year Book Europe Ltd; 1994:9.7-9.30.
2. Green K. Ocular effects of diacetyl morphine and lysergic acid diethylamide in rabbit. Invest Ophthalmol 1975;14:325-329.
3. Uusitalo R. The action of physostigmine, morphine, cyclopentolate and homatropine on the secretion and outflow of aqueous humor in the rabbit eye. Acta Physiol Scand 1972;86:239-249.
4. Leopold IH, Comroe JH. Effect of intramuscular administration of morphine, atropine, scopolamine, neostigmine on the human eye. Arch Ophthalmol 1948;40:285-290.
5. Simon EJ, Gioannini TL. Opioid receptor multiplicity: isolation, purification, and chemical characterization of binding sites. In: Herz A, ed. Opioids I. Berlin: Springer-Verlag; 1993:3-26.
6. Russell KR, Potter DE. Dynorphin modulates ocular hydrodynamics and releases atrial natriuretic peptide via activation of kappa-opioid receptors. Exp Eye Res 2002;75:259-270.
7. Potter DE, Russell KRM, Manhiani M. Bremazocine increases C-type natriuretic peptide levels in aqueous humor and enhances outflow facility. J Pharmacol Exp Ther 2004;309:548-553.
8. Moore TT, Potter DE. Kappa opioid agonist-induced changes in IOP: correlation with 3H-NE release and cAMP accumulation. Exp Eye Res 2001;73:167-178.
9. Russell KR, Wang DR, Potter DE. Modulation of ocular hydrodynamics and iris function by bremazocine, a kappa opioid receptor agonist. Exp Eye Res 2000;70:675-682.
10. Russell KR, Moore TT, Potter DE. Elevation of atrial natriuretic peptide levels in aqueous humor of the rabbit by kappa opioid receptor agonists. Neuropeptides 2001;35:232-237.
11. Takashima Y, Taniguchi T, Yoshida M, et al. Ocular hypotension induced by intravitreally injected C-type natriuretic peptide. Exp Eye Res 1998;66:89-96.
12. Korenfeld MS, Becker B. Atrial natriuretic peptides: effects on intraocular pressure, cGMP, and aqueous flow. Invest Ophthalmol Vis Sci 1989;30:2385-2392.
13. Ensinger H, Hedler L, Szabo B, Starke K. Bremazocine causes sympatho-inhibition and hypotension in rabbits by activating peripheral kappa-receptors. J Cardiovasc Pharmacol 1986;8:470-475.
14. Russell KR, Potter DE. Biphasic alterations of cAMP levels and inhibition of norepinephrine release in iris-ciliary body by bremazocine. J Pharmacol Exp Ther 2001;298:941-946.
15. Dortch-Carnes J, Potter DE. Inhibition of cAMP accumulation by kappa-receptor activation in isolated iris ciliary bodies: role of phosphodiesterase and protein kinase C. J Pharmacol Exp Ther 2002;301:599-604.
16. Dortch-Carnes J, Potter DE. Delta-opioid agonist-stimulated inositol phosphate formation in isolated, rabbit iris-ciliary bodies: role of G(i/o) proteins and Gbetagamma-subunits. Exp Eye Res 2003;77:647-652.
17. Dortch-Carnes J, Potter DE. Effect of bremazocine, a kappa-opioid receptor agonist, on inositol phosphate formation in isolated iris-ciliary bodies. Pharmacology 2002;66:100-106.
18. Pang I-H, Shade DL, Matsumoto S, Steely T, DeSantis L. Presence of functional type B natriuretic peptide receptor in human ocular cells. Invest Ophthalmol Vis Sci 1996;37:1724-1731.
19. Kee C, Kaufman PL, Gabelt BT. Effect of 8-Br cGMP on aqueous humor dynamics in monkeys. Invest Ophthalmol Vis Sci 1994;35:2769-2773.
20. Butelman ER, Negus SS, Ai Y, de Costa BR, Woods JH. Kappa opioid antagonist effects of systemically administered norbinaltorphimine in a thermal antinociception assay in rhesus monkeys. J Pharmacol Exp Ther 1993;267:1269-1276.
21. Ko MC, Butelman ER, Woods JH. Activation of peripheral kappa opioid receptors inhibits capsaicin-induced thermal nociception in rhesus monkeys. J Pharmacol Exp Ther 1999;289:378-385.
22. Ko MC, Johnson MD, Butelman ER, Willmont KJ, Mosberg HI, Woods JH. Intracisternal nor-binaltorphimine distiguishes central and peripheral kappaopioid antinociception in rhesus monkeys. J Pharmacol Exp Ther 1999;291:1113-1120.
23. Bonfiglio V, Bucolo C, Camillieri G, Drago F. Possible involvement of nitric oxide in morphine-induced miosis and reduction of intraocular pressure in rabbits. Eur J Pharmacol 2006;534:227-232.
24. Robinson JC, Kaufman PL. Superior cervical ganglionectomy in monkeys: surgical technique. Invest Ophthalmol Vis Sci 1992;33:247-251.
25. Kaufman PL, Davis GE. "Minified" Goldmann applanating prism for tonometry in monkeys and humans. Arch Ophthalmol 1980;98:542-546.
26. Grunwald JE, Piltz J, Hariprasad SM, DuPont J. Optic nerve and choroidal circulation in glaucoma. Invest Ophthalmol Vis Sci 1998;39:2329-2336.
27. Burstein NL, Anderson JA. Corneal penetration and ocular bioavailablility of drugs. J Ocul Pharmacol 1985;1:309-326.
28. Bárány EH. Simultaneous measurement of changing intraocular pressure and outflow facility in the vervet monkey by constant pressure infusion. Invest Ophthalmol 1964;3:135-143.
29. Kaufman PL, True-Gabelt BA, Erickson-Lamy KA. Time-dependence of perfusion outflow facility in the cynomolgus monkey. Curr Eye Res 1988;7:721-726.
30. Schoenwald RD. Ocular pharmacokinetics. In: Zimmerman MB, Kooner KS, Sharir M, Fechtner RD, eds. Textbook of Ocular Pharmacology. Philadelphia: Lippincott-Raven; 1997:119-138.
31. Erickson-Lamy KA, Kaufman PL, McDermott ML, France NK. Comparative anesthetic effects on aqueous humor dynamics in the cynomolgus monkey. Arch Ophthalmol 1984;102:1815-1820.
32. Tian B, Kiland JA, Kaufman PL. Effects of the marine macrolides swinholide A and jasplakinolide on outflow facility in monkeys. Invest Ophthalmol Vis Sci 2001;42:3187-3192.
33. Brandt CR, Pumfery AM, Micales B, et al. Renin mRNA is synthesized locally in rat ocular tissues. Curr Eye Res 1994;13:755-763.
34. Sramek SJ, Wallow IH, Tewksbury DA, Brandt CR, Poulsen GL. An ocular renin-angiotensin system. Immunohistochemistry of angiotensinogen. Invest Ophthalmol Vis Sci 1992;33:1627-1632.
35. Danser AHG, Derkx FHM, Admiraal PJJ, Deinum J, de Jong PTVM, Schalekamp MADH. Angiotensin levels in the eye. Invest Ophthalmol Vis Sci 1994;35:1008-1018.
36. Kiel JW, Reitsamer HA. Relationship between ciliary blood flow and aqueous production: does it play a role in glaucoma therapy? J Glaucoma 2006;15:172-181.
37. Bill A. The effect of changes in arterial blood pressure on the rate of aqeuous humour formation in a primate (Cercopithecus ethiops). Ophthal Res 1970;1:193-200.
38. Bill A. Circulation in the eye. In: Renkin EM, Michel CC, eds. The Cardiovascular System IV. Washington, DC: American Physiological Society; 1984:1001-1034.
39. Gabelt BT, Kaufman PL. Aqueous humor hydrodynamics. In: Kaufman PL, Alm A, eds. Adler's Physiology of the Eye: Clinical Application. St Louis: Mosby; 2003:237-289.
40. Bill A. Formation and drainage of aqueous humor in cats. Exp Eye Res 1966;5:185-190.
41. Reitsamer HA, Posey M, Kiel JW. Effects of a topical alpha2 adrenergic agonist on ciliary blood flow and aqueous production in rabbits. Exp Eye Res 2006;82:405-415.
42. Gabelt BT, Robinson JC, Hubbard WC, et al. Apraclonidine and brimonidine effects on anterior ocular and cardiovascular physiology in normal and sympathectomized monkeys. Exp Eye Res 1994;59:633-644.
43. Trzeciakowski JP. Central control of intraocular pressure. J Ocul Pharmacol 1987;3:367-378.
44. Krupin T, Posdos SM, Lehman RAW, Becker B. Effects of optic nerve transection on intraocular pressure in monkeys. Arch Ophthalmol 1970;84:668-671.
45. Ko MC, Willmont KJ, Burritt A, Hruby VJ, Woods JH. Local inhibitory effects of dynorphin A-(1-17) on capsaicin-induced thermal allodynia in rhesus monkeys. Eur J Pharmacol 2000;402:69-76.
46. Negus SS. Effects of the kappa opioid agonist U50,488 and the kappa opioid antagonist nor-binaltorphimine on choice between cocaine and food in rhesus monkeys. Psychopharmacology 2004;176:201-213.
47. Ko MCH, Willmont KJ, Lee H, Flory GS, Woods JH. Ultra-long antagonism of kappa opioid agonist-induced diuresis by intracisternal nor-binaltorphimine in monkeys. Brain Res 2003;982:38-44.
48. Endoh T, Tajima A, Izumimoto N, et al. TRK-820, a selective kappa-opioid agonist, produces potent antinociception in cynomolgus monkeys. Jpn J Pharmacol 2001;85:282-290.
49. 2 analysis in rhesus monkeys. J Pharmacol Exp Ther 1998;285:518-526.
50. Williams KL, Woods JH. Oral ethanol-reinforced responding in rhesus monkeys: effects of opioid antagonists selective for the mu-, kappa-, or delta-receptor. Alcoholism: Clin Exp Res 1998;22:1634-1639.
51. 2-agonist (UK14304-18) in cats, rabbits, and monkeys. Curr Eye Res 1986;5:665-676.
52. Bito LZ. Species differences in the response of the eye to irritation and trauma: a hypothesis of divergence in ocular defense mechanisms, and the choice of experimental animals for eye research. Exp Eye Res 1984;39:807-829.
53. Gabelt BT, Robinson JC, Gange SJ, Kaufman PL. Superior cervical ganglionectomy in monkeys: aqueous humor dynamics and their responses to drugs. Exp Eye Res 1995;60:575-584.
54. Samuelsson-Almén M, Nilsson SFE, Mäepea O, Bill A. Effects of atrial natriuretic factor (ANF) on intraocular pressure and aqueous humor flow in the cynomolgus monkey. Exp Eye Res 1991;53:253-260.